The NHS acne treatment path is slower than private care because the system is structurally designed to be slow. A mandatory stepped-care model forces patients through months of topical creams and oral antibiotics before a dermatology referral is even considered, and once that referral is made, the average wait to actually begin specialist treatment is around 43 weeks. Compare that to private care, where a patient can book a dermatologist consultation within days and potentially start isotretinoin inside of two weeks. The gap is not a matter of weeks — it can be a year or more. Consider someone with moderate-to-severe cystic acne who visits their GP in January. They will likely be prescribed a topical retinoid like Adapalene or a topical antibiotic such as Clindamycin.
If that fails after a few months, they move to oral antibiotics — Lymecycline or Doxycycline — which must be trialled for three to six months before escalation. Assuming both courses fail, a referral to a hospital dermatologist is submitted. But only 64% of dermatology patients are seen within the NHS’s own 18-week target, and the average wait from referral to treatment commencement sits at roughly 43 weeks. That January GP visit could easily become a December or even following-year dermatology appointment. Meanwhile, the acne scars. This article breaks down exactly why the NHS pathway takes so long, what regulatory and workforce barriers contribute to the delay, how private care sidesteps these bottlenecks, what the real costs look like for going private, and whether there are ways to work within the NHS system more effectively.
Table of Contents
- Why Does the NHS Require a Stepped Acne Treatment Path Before Referral?
- How Long Are NHS Dermatology Waiting Times Across the UK?
- The Workforce Crisis Behind NHS Dermatology Delays
- What Does Private Acne Treatment Cost and Is It Worth the Speed?
- Risks of the NHS Delay That Go Beyond Inconvenience
- Can You Speed Up the NHS Path Without Going Fully Private?
- What Needs to Change and Where Is NHS Dermatology Heading?
- Conclusion
- Frequently Asked Questions
Why Does the NHS Require a Stepped Acne Treatment Path Before Referral?
The NHS operates on a stepped-care model that is rational in theory but punishing in practice for patients with persistent acne. GPs are the first and only point of contact for months. Treatment begins at the lowest rung — topical retinoids or topical antibiotics — and only escalates when a course has been completed and documented as ineffective. According to NHS Cornwall’s referral criteria, dermatology referrals for mild-to-moderate acne require the failure of at least two completed treatment courses, typically a topical agent followed by a full round of oral antibiotics. The Nottinghamshire Area Prescribing Committee guidelines mirror this: you must demonstrate that both topical and oral antibiotics have been adequately tried before a consultant will see you. The oral antibiotic stage alone accounts for three to six months. NHS Scotland’s acne pathway specifies that Lymecycline or Doxycycline should be trialled for this duration before any referral is considered. This is not optional or at the GP’s discretion — it is a gatekeeping requirement baked into commissioning guidelines.
The clinical rationale is that many patients do respond to these first-line treatments, and it would be wasteful to flood specialist clinics with cases that a GP can resolve. The problem is that for the significant minority whose acne does not respond, these months represent enforced waiting with active, scarring disease. There is also a hard regulatory barrier at the top of the treatment ladder. GPs cannot prescribe isotretinoin. Only a hospital consultant dermatologist can initiate and monitor Roaccutane. This means that no matter how obvious it is that a patient needs isotretinoin, there is no shortcut through the GP’s surgery. The prescription pad simply does not allow it. This single rule is arguably the largest structural reason the NHS path is slower — it creates an unavoidable bottleneck at the specialist level for every patient who needs the most effective acne medication available.
How Long Are NHS Dermatology Waiting Times Across the UK?
Once a GP does make a dermatology referral, the waiting begins in earnest. Data compiled from cross-hospital samples shows the average NHS dermatology wait from referral to commencing treatment is approximately 43 weeks. That is not 43 weeks to be seen for a chat — that is 43 weeks before treatment actually starts. The NHS operational standard targets 92% of patients being seen within 18 weeks, but dermatology falls well short: only 64% of patients hit that benchmark. Routine referral waits commonly exceed 12 to 18 weeks even in better-performing areas, with some regions reporting six months or more for non-urgent appointments. Regional disparities make this worse depending on where you live. Rural and northern areas of the UK face the longest delays, while urban centres like London tend to be shorter but still significantly bottlenecked.
If you are a 17-year-old in a rural part of Wales or northern England, your wait could sit at the extreme end of these ranges. The postcode lottery is real, and it compounds the frustration of a condition that is already psychologically distressing. However, there is a nuance worth flagging: if your acne is assessed as severe or if there are significant mental health concerns documented alongside it, GPs can sometimes push for an urgent or expedited referral. This does not guarantee a fast appointment, but it can move you up the queue. The limitation is that “severe” and “urgent” in dermatology triage often default to suspected skin cancers, which rightly take priority. Acne, even when it is destroying a young person’s confidence and leaving permanent scars, rarely qualifies as urgent in the same clinical framework. If your GP is sympathetic and thorough in their referral letter, it helps — but it is not a reliable workaround.
The Workforce Crisis Behind NHS Dermatology Delays
The waiting times are not simply a bureaucratic problem — they reflect a genuine shortage of dermatologists. Around 20% of NHS dermatology consultant posts are unfilled or covered by temporary locum doctors. About a third of dermatology units across the country report “very serious” staffing shortages, according to written evidence submitted to Parliament. Some units have been forced to close entirely to routine referrals, accepting only urgent skin cancer cases. When your local dermatology department is operating in survival mode, acne referrals sit in a growing pile. The numbers tell the story clearly. The UK had 833 dermatologists in 2010, growing to 1,284 by 2024.
That sounds like progress until you consider that dermatology referrals have increased by 30 to 40% over the same period. Demand has outstripped supply, and much of the increased demand comes from skin cancer screening and surveillance — work that is clinically urgent and cannot be deprioritised. A dermatologist spending their morning on melanoma checks is not available that afternoon for an acne patient, and there is no one else qualified to fill the gap. This workforce crunch has a compounding effect. When consultant posts sit empty, the remaining dermatologists carry heavier caseloads, leading to burnout and further attrition. Training new consultants takes years, and dermatology is one of the most competitive specialties to enter — there are simply not enough training posts to produce the volume of specialists the NHS needs. This is not a problem that resolves in a single funding cycle. For patients waiting today, it means the structural delays are unlikely to improve meaningfully in the near term.
What Does Private Acne Treatment Cost and Is It Worth the Speed?
Private dermatology flips the timeline entirely. Where the NHS path to isotretinoin can take nine to sixteen months or longer — combining months of GP-led treatment trials with a referral wait of 12 to 43 weeks — the private path can get a patient in front of a dermatologist within days to weeks. Isotretinoin can potentially be initiated at the first or second consultation, meaning a patient could begin the medication within one to two weeks of picking up the phone. The trade-off is cost, and it is not trivial. An initial private dermatology consultation typically runs between £250 and £400. The London Skin and Hair Clinic charges around £300, while Oxona Health lists initial appointments at £255. Follow-up appointments, which are required regularly throughout an isotretinoin course, cost £155 to £255 per visit depending on the provider.
The medication itself is relatively affordable — roughly £15 to £20 per 20mg for a 30-day supply — but the mandatory blood monitoring adds up. Private blood tests for isotretinoin range from £75 for home testing kits to £300 for clinic-based panels. Over a full six-to-eight-month Roaccutane course with regular monitoring, the total spend can reach well into the thousands. Whether this is “worth it” depends entirely on individual circumstances. For someone whose acne is actively scarring, who is experiencing significant psychological distress, and who faces a 40-plus-week NHS wait, the financial outlay may be a straightforward decision. For someone with milder acne that might genuinely respond to the earlier-stage treatments, paying privately to jump to isotretinoin could mean taking on a powerful drug with real side effects when a less aggressive option might have worked. The speed of private care is its selling point, but speed is not always the same as appropriateness.
Risks of the NHS Delay That Go Beyond Inconvenience
The slower NHS pathway is not just an administrative frustration — it carries clinical consequences. Acne is a scarring disease. Every month that inflammatory lesions remain active is a month during which permanent textural damage can occur. The stepped-care model’s insistence on exhausting first-line treatments before escalation means that patients with treatment-resistant acne are, in effect, required to scar for six to twelve months before they can access the medication most likely to help them. This is a known problem within dermatology, and it is one reason many dermatologists privately express discomfort with the rigidity of referral criteria. The psychological toll is equally real and equally under-weighted by the system.
Severe acne in adolescence and early adulthood correlates with depression, social withdrawal, and reduced educational and professional attainment. Waiting lists do not pause these effects. A teenager told in Year 11 that they need to complete two treatment courses before a referral — and then wait the better part of a year for a dermatology appointment — may not see a specialist until they are well into sixth form or beyond. The window of adolescent social development does not wait for NHS commissioning targets. There is a further limitation worth noting: even once a patient reaches a consultant, the isotretinoin pathway itself takes six to eight months of treatment with ongoing blood monitoring. So the total time from first GP visit to completing a course of Roaccutane on the NHS can exceed two years. Patients and parents should understand this full timeline upfront, because the referral appointment is not the finish line — it is roughly the halfway point.
Can You Speed Up the NHS Path Without Going Fully Private?
There are a few strategies that work within the system. First, be proactive and organised with your GP from the outset. If you know your acne is unlikely to respond to first-line topicals — perhaps because you have tried over-the-counter retinoids already, or because your acne is clearly nodular or cystic — say so clearly and ask your GP to document the severity thoroughly. Photographic evidence in the referral letter can make a material difference in how a triage team prioritises your case.
Second, some areas offer GP-with-extended-role (GPwER) services in dermatology, which can provide intermediate-level care faster than a full consultant referral. Ask your GP whether this pathway exists locally. Another option is a hybrid approach: see a private dermatologist for the initial consultation and diagnosis, then ask them to write to your GP recommending a specific treatment plan that the GP can prescribe and monitor on the NHS. This works for some treatments but has limits — isotretinoin still requires consultant-led monitoring, so you cannot hand it off to a GP mid-course. Still, for patients who can afford a single private appointment but not the full treatment cost, this halfway step can sometimes shortcut the diagnostic waiting time while keeping ongoing costs within the NHS.
What Needs to Change and Where Is NHS Dermatology Heading?
The fundamental bottleneck — too few dermatologists chasing too much demand — will not resolve quickly. Training a consultant dermatologist takes over a decade from medical school entry, and even if training posts were expanded tomorrow, the downstream effect would not be felt for years. In the shorter term, some NHS trusts are experimenting with teledermatology triage, where GPs upload photographs and clinical notes for remote consultant review. This can sometimes result in a treatment recommendation without the patient ever attending a clinic, effectively bypassing the physical appointment queue.
It is promising but inconsistently implemented across the country. There is also growing discussion within professional dermatology bodies about whether the stepped-care model itself needs reform for clearly severe presentations. If a GP can photograph nodular cystic acne and a consultant can remotely confirm that isotretinoin is appropriate, the months of mandatory first-line trials become harder to justify clinically. Whether commissioning bodies will act on this remains to be seen. For now, patients navigating the system should understand that the delays are structural, not accidental, and plan accordingly — whether that means budgeting for private care, advocating firmly within the NHS pathway, or combining both approaches strategically.
Conclusion
The NHS acne treatment path is slower than private care not because of any single failing, but because of overlapping structural factors: a mandatory stepped-care model that requires months of first-line treatment before referral, a regulatory barrier that reserves isotretinoin prescribing exclusively for hospital consultants, a workforce shortage that leaves a fifth of dermatology posts unfilled, and a referral system where only 64% of patients are seen within the NHS’s own 18-week target. The result is a potential nine-to-sixteen-month journey to reach isotretinoin on the NHS, versus as little as one to two weeks privately. For patients weighing their options, the decision comes down to clinical severity, financial capacity, and tolerance for waiting.
Those with mild acne may find the NHS pathway perfectly adequate. Those with scarring, treatment-resistant disease face a harder calculus, where the cost of private care must be weighed against the cost — both physical and psychological — of continued delay. Whatever path you choose, go in with realistic expectations about timelines, document everything, and advocate for yourself at every stage. The system is not designed to move fast for acne, so you may need to push it.
Frequently Asked Questions
Can my GP prescribe isotretinoin (Roaccutane) on the NHS?
No. Isotretinoin can only be initiated and monitored by a hospital consultant dermatologist. This is a hard regulatory restriction, not a matter of GP discretion. Your GP must refer you to a dermatologist before isotretinoin can be considered.
How long does the full NHS acne treatment pathway take before I can start isotretinoin?
Typically nine to sixteen months or more. This includes three to six months of GP-led trials with topical and oral treatments, followed by a referral wait that averages 43 weeks from referral to treatment commencement. Some patients wait significantly longer depending on their region.
How much does a full private isotretinoin course cost in the UK?
The initial consultation costs £250 to £400, follow-ups run £155 to £255 each, the medication is approximately £15 to £20 per month for a standard dose, and blood tests range from £75 to £300 per session. Over a six-to-eight-month course with regular monitoring, total costs can reach several thousand pounds.
Are NHS dermatology waiting times the same across the UK?
No. There are significant regional disparities. Rural and northern areas tend to face the longest waits, while urban centres like London are somewhat shorter but still under pressure. Some dermatology units have closed to routine referrals entirely due to staffing shortages, handling only urgent skin cancer cases.
Can I see a private dermatologist and then transfer back to the NHS?
Partially. A private dermatologist can write to your GP with treatment recommendations that the GP may be able to prescribe on the NHS. However, isotretinoin specifically requires ongoing consultant-led monitoring, so you cannot fully hand that treatment back to a GP mid-course.
What should I do while waiting for an NHS dermatology appointment?
Continue any treatment your GP has prescribed, document your skin condition with dated photographs, and report any worsening or significant psychological impact to your GP — this can sometimes support a request for expedited referral. Ask whether your area offers teledermatology triage or GP-with-extended-role dermatology services.
